Stem Cell Infusion + Total Body Irradiation + Cyclophosphamide + Mycophenolate Mofetil + TREOSULFAN + FLUDARABINE + Tacrolimus for myelodysplastic syndromes
A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set
Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.
Put together by software, not yet checked by a person
Why this status
25 Mar 2026: Trial registered, NCT07493538
10 Apr 2026: Trial started, NCT07493538
The trials
NCT07493538: MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases
State
Under way
Phase
Phase 2
People
132 planned
Started
10 Apr 2026
Primary completion
Mar 2030
Arms
Treo/Flu with PTCy
Results
None posted
25 Mar 2026: Trial registered
10 Apr 2026: Trial started
How the status changed
19 Nov 2026: First set: Phase 2 trial
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.